VCP
MRK icon

Verus Capital Partners’s Merck MRK Stock Holding History

Verus Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
8,378
+329
+4% +$38K 0.07% 172
2025
Q4 		$847K Sell
8,049
-778
-9% -$73K 0.06% 187
2025
Q3 		$741K Buy
8,827
+1,038
+13% +$85.5K 0.06% 181
2025
Q2 		$617K Sell
7,789
-72
-0.9% -$5.72K 0.05% 186
2025
Q1 		$706K Buy
7,861
+104
+1% +$9.71K 0.07% 159
2024
Q4 		$772K Sell
7,757
-311
-4% -$32.1K 0.07% 154
2024
Q3 		$918K Sell
8,068
-169
-2% -$20.1K 0.09% 138
2024
Q2 		$1.02M Buy
8,237
+1,170
+17% +$151K 0.11% 121
2024
Q1 		$932K Buy
7,067
+174
+3% +$21.4K 0.1% 123
2023
Q4 		$751K Buy
6,893
+1,027
+18% +$107K 0.09% 128
2023
Q3 		$604K Buy
5,866
+1,228
+26% +$132K 0.08% 136
2023
Q2 		$535K Buy
4,638
+279
+6% +$31.7K 0.08% 152
2023
Q1 		$464K Buy
4,359
+201
+5% +$21.7K 0.07% 162
2022
Q4 		$461K Sell
4,158
-57
-1% -$5.83K 0.09% 152
2022
Q3 		$363K Buy
4,215
+12
+0.3% +$1.07K 0.07% 186
2022
Q2 		$383K Sell
4,203
-1,436
-25% -$127K 0.08% 189
2022
Q1 		$488K Buy
+5,639
New +$445K 0.08% 178
2020
Q1 		$197K Buy
2,679
+826
+45% +$64.9K 0.06% 198
2019
Q4 		$161K Buy
+1,853
New +$152K 0.05% 270

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Verus Capital Partners's MRK Position: Q1 2026 in Review

Verus Capital Partners increased its Merck (MRK) stake by 4.1% in Q1 2026, buying an estimated $38K and bringing the position to 8,378 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #172.

Verus Capital Partners first reported a position in MRK in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.02M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Verus Capital Partners held 8,378 shares of Merck worth $1.01M as of Q1 2026.
  • Verus Capital Partners bought 329 Merck shares in Q1 2026, an estimated $38K.
  • Merck made up 0.07% of Verus Capital Partners's portfolio in Q1 2026, its #172 holding.
  • Verus Capital Partners first reported a position in Merck in Q4 2019 and has held it in 19 quarters since.
  • Verus Capital Partners's Merck position peaked at $1.02M in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.